Group items tagged

51st Annual Hawaii International Conference on System Sciences (HICSS) is organized by University of Hawaii at Manoa and would be held during Jan 03 - 06, 2018 at Hilton Waikoloa Village, Waikoloa, Hawaii, United States Of America.

40th Annual San Antonio Breast Cancer Symposium (SABCS) is organized by UT Health Science Center San Antonio and would be held during Dec 5 - 9, 2017 at Henry B. Gonzalez Convention Center, San Antonio, Texas, United States of America. This cme conference has been approved with a maximum of 38.50 AMA PRA Category 1 Credits. The target audience for this medical event for academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals. Symposium Objective : This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

Infectious Diseases Society of America (IDSA) : IDWeek is organized by Infectious Diseases Society of America (IDSA) and would be held during Oct 04 - 08, 2017 at San Diego Convention Center, San Diego, California, United States Of America. The target audience for this medical event for healthcare professionals in infectious diseases and healthcare epidemiology and prevention, including researchers, clinicians, quality and patient safety practitioners, epidemiologists, and public health officials, including those who see HIV and pediatric patients. It is a must-attend meeting for professionals who want to stay current, apply state-of-the art science to clinical care, and excel in their own careers. This CME Conference has been approved with a maximum of 41.75 AMA PRA Category 1 Credits.

Conjugated linoleic acid (CLA) supplementation is associated with an increase in serum C-reactive protein (CRP) concentration, according to a review and meta-analysis published online May 29 in Cardiovascular Therapeutics. Mohsen Mazidi, Ph.D., from the Chinese Academy of Sciences in Beijing, and colleagues conducted a systematic review and meta-analysis to examine the impact of CLA supplementation on serum CRP. Data were included from 14 studies. The researchers found that following supplementation with CLAs there was a significant increase in serum CRP concentrations (weighted mean difference, 0.63 mg/dL; 95 percent confidence interval, 0.13 to 1.13; heterogeneity P = 0.026); these findings were robust in sensitivity analyses. The changes in serum CRP levels were found to be independent of CLA supplementation dosage (slope, −0.02; 95 percent confidence interval, −0.10 to 0.12; P = 0.889) or follow-up duration (slope, 0.271; 95 percent confidence interval, −0.05 to 0.59; P = 0.098). "This meta-analysis suggests that CLA supplementation is associated with an increase in plasma CRP concentrations and a reduction in serum adiponectin concentrations, which indicates that CLA supplements have a pro-inflammatory effect," the authors write.